P05.07 Effect of Tumor-Treating Fields plus Short-Course Radiation with or without Temozolomide in Elderly Patients with Glioblastoma (GERAS Trial)

BACKGROUND: Despite advances in the therapy of glioblastomas (GBM) in the last decades, the most common malignancy of glial origin is still associated with poor prognosis. At present, maximal safe resection followed by adjuvant chemoradiotherapy (CRT) with temozolomide (TMZ) is the standard of care....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Höne, S J, Krisam, J, Jäkel, C, Schmitt, D, Lang, K, El Shafie, R, Adeberg, S, Unterberg, A, Rieken, S, Kieser, M, Debus, J, Bernhardt, D
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Poster Presentations
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6796028/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.121
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items